Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07206329) titled 'PEG-Asc Vs. SPMC for Bowel Preparation in Capsule-based Procedures' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: Double (Investigator, Outcomes Assessor).
Primary Sponsor: Unidade Local de Saude do Alto Ave, EPE
Condition:
Bowel Preparation Solution
Intervention:
Drug: Polyethylene Glycol plus Ascorbic Acid (PEG-Asc)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: January 1, 2024
Target Sample Size: 220
Countries of Recruitment:
Portugal
To know more, visit https://cl...